North America Bioresorbable Polymers Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type [Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polydioxanone, Polycaprolactone (PCL), and Others] and Application (Orthopedic Devices, Drug Deli

North America Bioresorbable Polymers Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type [Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polydioxanone, Polycaprolactone (PCL), and Others] and Application (Orthopedic Devices, Drug Delivery, and Others)

The bioresorbable polymers market in North America is expected to grow from US$ 1,189.92 million in 2021 to US$ 2,499.56 million by 2028; it is estimated to grow at a CAGR of 11.2% from 2021 to 2028.

The demand for bioresorbable-based medical implants and wound dressing covers is increasing due to their self-dissolving properties in the human body. Bioresorbable polymers such as polylactic acid, polycaprolactone, and polydioxanone are widely used to manufacture screws, pins, rods, plates scaffolds, sutures, stents, and other medical implant devices. Furthermore, these polymers are also used as controlled drug release implants inside the human body. Once the recovery of the patients’ organs begins, these implants gradually start dissolving and are entirely absorbed in the body after the fulfillment of their function. As the body itself absorbs these bioresorbable implants, patients do not require a second surgical intervention to remove them. Thus, improved clinical outcomes and cost-effectiveness associated with these implants are supporting the market growth. Further, bioresorbable polymers are witnessing a surge in their demand due to their increased applications for wound management. Bioresorbable-based synthetic polymer wraps are widely used for wound dressing and covering since they provide a barrier against bacterial penetration as well as oxygen permeability to the wound. The polymer is also used to manufacture bioresorbable wraps and sheets that are extremely thin and transparent foils capable of holding tissue masses in place and facilitating post-surgery healing. In addition, bioresorbable polymer powders are used for dermal filler applications. Dermal fillers, also known as soft tissue fillers, are injected into the skin using a minor surgical procedure to plump thin lips, enhance shallow contours, soften facial creases, remove wrinkles, and improve the appearance of scars.

The US reported the highest number of COVID-19 cases among all key countries in North America, which obstructed manufacturing processes, research, and development activities in the region. The shutdown of manufacturing other operational units hampered the bioresorbable polymer market. The halt in the production of medical devices and delays in non-essential surgeries during the pandemic also hampered the market growth in 2020. A study on orthopedic surgery volumes by the Journal of Bone and Joint Surgery, in May 2020, stated that the US is expected to face a cumulative backlog of more than a million total joint and spine surgery cases by mid-2022, which will limit the demand of medical implants. However, the reopening of manufacturing facilities after the relaxation on lockdown is aiding the resurgence of the bioresorbable polymer market activities.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America bioresorbable polymers market at a good CAGR during the forecast period.

North America Bioresorbable Polymers Market Revenue and Forecast to 2028 (US$ Million)

North America Bioresorbable Polymers Market Segmentation

North America Bioresorbable Polymers Market, by Type

Polylactic Acid (PLA) Polyglycolic Acid (PGA) Polydioxanone Polycaprolactone(PCL) Others North America Bioresorbable Polymers Market, by Application

Orthopedic Devices Drug Delivery Other Application North America Bioresorbable Polymers Market, by Country

US Canada Mexico North America Bioresorbable Polymers Market - Companies Mentioned

Evonik Industries AG Musashino Chemical Laboratory, Ltd. Ashland Global Holdings Inc. Poly-Med Incorporated Foster Corporation REVA Medical, LLC Polysciences Inc. Bezwada Biomedical LLC

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America bioresorbable polymers market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America bioresorbable polymers market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the bioresorbable polymers market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution